Publicaciones científicas
Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis
30-mar-2023
| Revista: Hemasphere
Miguel A Canales 1 , Thomas A Buchholz 2 , Jaisson A P Bortolini 3 , Laura M Fogliatto 4 , Takayuki Ishikawa 5 , Koji Izutsu 6 , Antonio Salar 7 , Jeff P Sharman 8 , Dirk Klingbiel 9 , Sunny Pokala 9 , Ekaterina Vorozheikina 10 , Peter Trask 11 , Joana Parreira 9 , Kai Hübel 12
Resumen no disponible
CITA DEL ARTÍCULO Hemasphere. 2023 Mar 30;7(4):e860. doi: 10.1097/HS9.0000000000000860